Clinical trials
No longer available Leukemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| No longer available | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Barbara Ann Karmanos Cancer Institute | 1 |
| Christopher Dvorak | 1 |
| Novartis Pharmaceuticals | 1 |
| OHSU Knight Cancer Institute | 1 |
| Syndax Pharmaceuticals | 1 |
| UNC Lineberger Comprehensive Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 6 |
| Leukemia, Myeloid, Acute | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Immune System Diseases | 2 |
| Immunoproliferative Disorders | 2 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
| Lymphoma | 2 |
| Myelodysplastic Syndromes | 2 |
| Precancerous Conditions | 2 |
| Recurrence | 2 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.